| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000271803.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.045054495 |
Sensitive |
| ENSG00000271803.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.034835415 |
Sensitive |
| ENSG00000271803.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.028240557 |
Sensitive |
| ENSG00000271803.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.043373013 |
Sensitive |
